Physician profile
Michaela E Place
NPI 1477125821
$2,295.77
in general payments reported to CMS, 2019-2025
21 companies · $415 in 2025
The $415 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $325 · 2023: $646 · 2024: $910 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,970.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $434.26 | 2023-2025 | |
| Lilly USA, LLC | $399.40 | 2022-2025 | Zepbound, Jardiance, Mounjaro |
| Abbott Laboratories | $319.87 | 2024-2025 | Freestyle Libre, Freestyle Libre 3 |
| Abbvie INC. | $239.80 | 2022-2024 | |
| Exact Sciences Corporation | $175.22 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.42 | 2022-2024 | Jardiance |
| Novo Nordisk INC | $97.05 | 2022-2025 | Wegovy, Saxenda, Ozempic |
| Idorsia Pharmaceuticals US INC | $78.65 | 2023-2024 | Quviviq |
| Biohaven Pharmaceutical Holding Company Ltd. | $54.71 | 2022 | |
| Dexcom, INC. | $54.15 | 2024-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $54.05 | 2023-2024 | Shingrix, Arexvy, Bexsero |
| Janssen Pharmaceuticals, INC | $49.39 | 2023 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $45.03 | 2022-2024 | Farxiga |
| Merck Sharp & Dohme LLC | $35.68 | 2023-2024 | Dificid, Gardasil 9, Gardasil |
| Medtronic, INC. | $31.54 | 2023-2024 | Venaseal |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $28.90 | 2023 | Azstarys |
| Alk-Abello, INC | $23.13 | 2025 | Neffy, Odactra, Ragwitek |
| Boston Scientific Corporation | $22.91 | 2022 | |
| Inspire Medical Systems, INC. | $19.33 | 2023 | Inspire |
| Sanofi Pasteur INC. | $18.53 | 2022 | |
| Ethicon US, LLC | $14.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michaela Place listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.